Mallinckrodt Dodges MS Drug Monopoly Suit
An Illinois federal judge on Monday dismissed claims that drugmaker Mallinckrodt conspired with Express Scripts to artificially inflate the price of a drug used to treat infant seizures and multiple sclerosis,...To view the full article, register now.
Already a subscriber? Click here to view full article